STOCKHOLM, Jan. 30, 2020 /PRNewswire/ -- IRRAS will host a
conference call and an online presentation of its Q4 2019 interim
report (which will have been published earlier on the
14th at 08.00 a.m. CET).
The presentation will be held in English.
The dial-in numbers for the conference call are:
Sweden: +46 8 56 64 27
03
Rest of the world: +44 33 33 00 92 67
The presentation will be webcast and can be accessed from the
following web address:
https://tv.streamfabriken.com/irras-q4-2019
Speakers: President CEO Kleanthis G.
Xanthopoulos, Ph.D., CCO Will Martin and CFO Sabina Berlin
About IRRAS
IRRAS AB is a global healthcare company focused on delivering
innovative medical technologies to our customers and their
patients. IRRAS designs, develops and commercializes products that
improve patient outcomes and decrease the overall cost of care by
addressing complications associated with current treatment methods
in neurocritical care. IRRAS currently markets and sells its
IRRAflow and Hummingbird product lines to hospitals
worldwide through its direct sales organizations in the U.S. and
select European countries and a network of distribution partners in
other markets.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS AB (publ) is listed on Nasdaq First North Premier Growth
Market (ticker: IRRAS). Redeye AB is Certified Adviser of the
company with email certifiedadviser@redeye.se or phone +46-8-
121-576-90.
For more information, please contact:
USA
Kleanthis G. Xanthopoulos, Ph.D.
President and CEO
ir@irras.com
Europa
Sabina Berlin
CFO
+46-73-951-95-02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on January 30, 2020 at 8:00 a.m. (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/q4-report-2019---invitation-to-conference-call-and-audiocast,c3021693